X @Bloomberg
Bloomberg·2025-12-15 10:04

Argenx fell the most in seven months after saying it will discontinue late-stage trials for an experimental medicine to treat an autoimmune disease affecting the eyes https://t.co/k2EKHoz0U8 ...